Cochrane announces funding support for 10 new Cochrane Reviews

The Cochrane Editorial Unit is pleased to announce the 10 successful titles from the second Cochrane Review Support Programme (CRSP) funding round.Delayed antibiotics for respiratory infections (Acute Respiratory Infections Group) Bisphosphonates and other bone agents for breast cancer (Breast Cancer Group)Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises (Common Mental Disorders Group)Drug eluting stents versus bare metal stents for acute coronary syndrome (Heart Group)Withdrawal of antihypertensive drugs in older people (Hypertension Group)Pharmacotherapy for hypertension in adults aged 18 to 59 years (Hypertension Group)Interventions for preventing obesity in children (Public Health Group)Taxation of sugar-sweetened beverages for reducing their consumption and preventing obesity or other adverse health outcomes (Public Health Group)Interventions for treating depression after stroke (Stroke Group)Interventions to prevent occupational noise-induced hearing loss (Work Group)We received 23 applications from 16 Groups. To evaluate the applications we convened an international assessment panel comprising nine Cochrane contributors and consumers of Cochrane Reviews, who generously shared their time and expertise:Dr Urbà González, Unit of Dermatology, CLĺNICA GO&FER, Barcelona, SpainProf Sally Green, Australasian Cochrane Centre, Monash University, Melbourne, AustraliaDr Devan Kansagara MD, MCR,...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news